Drugplain

Viltepso 250 mg/1

viltolarsen · INJECTION, SOLUTION · NS Pharma, Inc.

No Recall History
Plain English

Viltepso is a injection, solution containing viltolarsen at 250 mg/1, taken intravenous. Manufactured by NS Pharma, Inc..

Key Facts

Brand Name
Viltepso
Generic Name
viltolarsen
NDC Code (Product)
73292-011
Manufacturer
NS Pharma, Inc.
Strength
250 mg/1
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS
Marketing Status
Application #
NDA212154
Marketing Start
08/13/2020

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

pyrexia19 reports
illness10 reports
vomiting10 reports
pneumonia8 reports
malaise7 reports
weight increased7 reports
covid-196 reports
cough5 reports
fall5 reports
product dose omission issue5 reports

Frequently Asked Questions

What is Viltepso used for?

Viltepso contains viltolarsen. It is a injection, solution taken intravenous. Consult your doctor for specific uses.

Is Viltepso a controlled substance?

Viltepso is not classified as a controlled substance by the DEA.

What is the generic name for Viltepso?

The generic name for Viltepso is viltolarsen. There are no other listed brand versions of viltolarsen.

What is the NDC code for Viltepso 250 mg/1?

The NDC (National Drug Code) for Viltepso 250 mg/1 is 73292-011, listed by NS Pharma, Inc..

Product NDC

73292-011

Package NDC

73292-011-01

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)